0005

COM:SAMIL-PHARM

삼일제약

  • Stock

Last Close

12,900.00

25/11 06:11

Market Cap

169.82B

Beta: -

Volume Today

368.21K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
16.58B
-
15.57B
6.13%
14.99B
3.73%
12.91B
13.89%
13.90B
7.71%
20.17B
45.10%
23.15B
14.74%
23.25B
0.44%
24.13B
3.79%
24.46B
1.36%
12.37B
49.42%
average payables
6.44B
-
5.95B
7.60%
6.02B
1.26%
6.04B
0.36%
7.49B
23.91%
9.12B
21.83%
9.18B
0.63%
9.98B
8.66%
9.68B
2.95%
11.10B
14.63%
6.83B
38.47%
average receivables
32.17B
-
34.28B
6.58%
35.39B
3.22%
36.24B
2.42%
35.58B
1.83%
29.51B
17.06%
25.66B
13.03%
29.12B
13.46%
34.25B
17.61%
36.65B
7.00%
18.01B
50.85%
book value per share
5.90K
-
4.73K
19.88%
4.67K
1.18%
4.56K
2.43%
4.40K
3.44%
4.83K
9.66%
4.64K
3.77%
4.73K
1.77%
4.75K
0.52%
10.29K
116.65%
capex per share
-158.57
-
-493.38
211.15%
-217.73
55.87%
-383.83
76.29%
-3.73K
871.14%
-336.97
90.96%
-1.08K
220.48%
-1.28K
18.52%
-2.39K
86.82%
-3.98K
66.46%
capex to depreciation
-0.53
-
-1.69
217.75%
-0.83
50.77%
-1.42
69.59%
-11.90
740.79%
-1.06
91.07%
-3.61
239.42%
-4.10
13.65%
-7.02
71.35%
-9.75
38.87%
capex to operating cash flow
0.47
-
0.49
2.84%
-0.87
279.04%
-0.79
9.01%
-11.43
1,346.48%
1.49
113.07%
-1.37
191.54%
-2.21
61.90%
-23.35
955.01%
-11.71
49.85%
capex to revenue
-0.02
-
-0.07
220.86%
-0.03
57.48%
-0.05
59.93%
-0.47
923.29%
-0.04
91.21%
-0.12
188.85%
-0.14
17.03%
-0.25
76.16%
-0.27
9.86%
cash per share
1.97K
-
962.56
51.10%
464.50
51.74%
704.04
51.57%
85.25
87.89%
945.63
1,009.20%
2.22K
134.62%
1.28K
42.36%
1.10K
13.77%
155.72
85.88%
days of inventory on hand
107.48
-
109.88
2.24%
104.03
5.33%
74.82
28.07%
117.54
57.09%
145.72
23.98%
109.98
24.52%
118.85
8.06%
103.50
12.91%
80.50
22.23%
days payables outstanding
41.06
-
41.98
2.24%
44.01
4.81%
39.37
10.54%
64.34
63.45%
56.36
12.40%
44.80
20.52%
53.42
19.25%
36.57
31.55%
44.44
21.54%
days sales outstanding
138.36
-
148.38
7.24%
149.22
0.57%
137.51
7.84%
137.62
0.08%
93.82
31.83%
81.42
13.22%
92.66
13.81%
101.34
9.36%
73.18
27.79%
debt to assets
0.22
-
0.33
48.77%
0.28
15.06%
0.30
5.31%
0.45
51.07%
0.45
0.19%
0.51
12.94%
0.49
3.27%
0.55
12.55%
0.45
19.46%
debt to equity
0.37
-
0.65
75.94%
0.52
20.66%
0.57
10.21%
1.20
109.40%
1.19
0.55%
1.50
26.41%
1.49
1.21%
1.91
28.52%
1.27
33.70%
dividend yield
0.03
-
0.03
0.34%
0.03
0.83%
0.02
12.05%
0.02
31.14%
0.01
57.25%
0.00
33.03%
0.01
53.41%
0.01
22.58%
0.01
17.37%
earnings yield
0.28
-
-0.39
241.59%
0.02
104.06%
0.02
32.53%
-0.03
231.15%
-0.08
189.01%
0.01
107.71%
0.01
73.74%
-0.05
578.61%
-0.00
99.42%
enterprise value
31.47B
-
63.65B
102.26%
61.98B
2.61%
66.32B
7.00%
106.27B
60.23%
171.48B
61.35%
205.21B
19.67%
204.31B
0.44%
226.44B
10.83%
252.70B
11.60%
enterprise value over ebitda
1.80
-
-11.29
725.75%
12.69
212.36%
9.52
24.98%
22.00
131.06%
-91.55
516.17%
21.59
123.58%
18.32
15.14%
39.27
114.38%
26.02
33.74%
ev to operating cash flow
-7.89
-
-5.34
32.31%
21.23
497.66%
11.77
44.55%
28.03
138.12%
-65.41
333.36%
19.38
129.62%
26.28
35.62%
159.82
508.17%
60.83
61.94%
ev to sales
0.35
-
0.74
111.18%
0.70
5.57%
0.69
2.53%
1.15
68.45%
1.81
56.98%
1.69
6.52%
1.66
1.97%
1.69
1.55%
1.41
16.62%
free cash flow per share
-494.73
-
-1.51K
205.31%
32.96
102.18%
101.88
209.07%
-3.40K
3,438.75%
-562.56
83.46%
-290.14
48.43%
-701.77
141.88%
-2.29K
226.15%
-3.64K
59.06%
free cash flow yield
-0.20
-
-0.62
202.57%
0.01
101.67%
0.03
170.72%
-0.86
3,172.24%
-0.06
92.93%
-0.03
50.02%
-0.07
147.16%
-0.30
302.80%
-0.47
54.61%
graham net net
915.42
-
-664.18
172.55%
-449.04
32.39%
-599.01
33.40%
-4.22K
604.38%
-4.36K
3.40%
-4.50K
3.22%
-5.61K
24.60%
-7.61K
35.68%
-15.51K
103.72%
graham number
9.42K
-
10.08K
6.99%
2.30K
77.13%
2.80K
21.50%
3.28K
17.31%
8.94K
172.35%
2.48K
72.33%
3.26K
31.54%
6.43K
97.37%
732.06
88.61%
income quality
-0.50
-
1.07
311.77%
4.96
365.74%
6.35
28.05%
-2.99
147.11%
0.31
110.23%
13.47
4,299.33%
5.80
56.94%
-0.26
104.57%
-146.85
55,314.86%
intangibles to total assets
0.04
-
0.02
57.75%
0.02
9.63%
0.02
0.64%
0.01
43.16%
0.01
8.15%
0.01
11.37%
0.01
4.35%
0.01
36.48%
0.01
53.71%
0
100%
interest coverage
-1.46
-
-6.24
327.95%
1.34
121.41%
3.53
164.75%
0.74
79.12%
-2.39
424.24%
1.24
151.63%
1.19
3.89%
0.17
85.68%
0.94
454.03%
interest debt per share
2.30K
-
3.21K
39.09%
2.52K
21.26%
2.70K
6.86%
5.42K
100.79%
5.95K
9.79%
7.27K
22.32%
7.43K
2.15%
9.52K
28.10%
13.38K
40.54%
inventory turnover
3.40
-
3.32
2.19%
3.51
5.63%
4.88
39.03%
3.11
36.34%
2.50
19.34%
3.32
32.49%
3.07
7.46%
3.53
14.82%
4.53
28.58%
invested capital
0.37
-
0.65
75.94%
0.52
20.66%
0.57
10.21%
1.20
109.40%
1.19
0.55%
1.50
26.41%
1.49
1.21%
1.91
28.52%
1.27
33.70%
market cap
28.83B
-
28.73B
0.34%
37.20B
29.45%
42.29B
13.70%
46.07B
8.92%
107.76B
133.93%
128.30B
19.06%
125.91B
1.87%
104.92B
16.67%
95.35B
9.12%
net current asset value
27.14B
-
8.65B
68.13%
11.01B
27.36%
7.83B
28.88%
-32.15B
510.42%
-32.68B
1.65%
-42.40B
29.75%
-55.59B
31.09%
-83.95B
51.02%
-156.10B
85.95%
net debt to ebitda
0.15
-
-6.20
4,196.79%
5.07
181.92%
3.45
32.02%
12.46
261.26%
-34.02
372.96%
8.09
123.78%
7.03
13.12%
21.07
199.80%
16.20
23.12%
net income per share
668.09
-
-954.48
242.87%
50.51
105.29%
76.43
51.30%
-108.93
242.53%
-736.82
576.39%
58.64
107.96%
99.70
70.03%
-386.36
487.54%
-2.31
99.40%
operating cash flow per share
-336.17
-
-1.02K
202.55%
250.69
124.65%
485.71
93.75%
326.09
32.86%
-225.59
169.18%
789.79
450.10%
578.20
26.79%
102.39
82.29%
339.82
231.90%
payables turnover
8.89
-
8.69
2.19%
8.29
4.59%
9.27
11.78%
5.67
38.82%
6.48
14.16%
8.15
25.81%
6.83
16.14%
9.98
46.10%
8.21
17.72%
receivables turnover
2.64
-
2.46
6.75%
2.45
0.56%
2.65
8.51%
2.65
0.08%
3.89
46.69%
4.48
15.23%
3.94
12.14%
3.60
8.56%
4.99
38.48%
research and ddevelopement to revenue
0.02
-
0.03
42.40%
0.01
61.11%
0.01
2.11%
0.02
64.34%
0.02
8.23%
0.03
9.55%
0.02
3.22%
0.02
9.47%
0.02
26.90%
return on tangible assets
0.07
-
-0.11
246.90%
0.01
105.74%
0.01
48.20%
-0.01
205.55%
-0.06
518.48%
0.00
107.38%
0.01
63.51%
-0.02
436.52%
-0.00
99.66%
0.01
7,089.78%
revenue per share
7.52K
-
7.29K
3.03%
7.57K
3.80%
8.34K
10.23%
7.92K
5.10%
8.14K
2.83%
9.03K
10.95%
9.15K
1.28%
9.70K
6.05%
14.70K
51.52%
roe
0.11
-
-0.20
278.31%
0.01
105.36%
0.02
55.08%
-0.02
247.61%
-0.15
516.80%
0.01
108.27%
0.02
67.07%
-0.08
485.52%
-0.00
99.72%
0.02
7,290.03%
roic
-0.01
-
-0.10
670.67%
0.01
110.52%
0.02
42.25%
0.02
34.32%
-0.05
337.32%
0.02
133.88%
0.05
177.14%
0.01
86.67%
-0.00
106.08%
0.08
20,738.45%
sales general and administrative to revenue
0.04
-
0.04
10.21%
0.05
14.30%
0.05
3.60%
0.05
7.22%
0.09
82.20%
0.06
31.05%
0.05
22.48%
0.06
14.01%
0.06
2.71%
shareholders equity per share
5.90K
-
4.73K
19.88%
4.67K
1.18%
4.56K
2.43%
4.40K
3.44%
4.83K
9.66%
4.64K
3.77%
4.73K
1.77%
4.75K
0.52%
10.29K
116.65%
stock based compensation to revenue
tangible asset value
64.98B
-
53.42B
17.79%
52.40B
1.90%
50.82B
3.03%
49.60B
2.39%
54.51B
9.90%
60.54B
11.06%
61.83B
2.12%
64.45B
4.25%
122.68B
90.35%
370.68B
202.14%
tangible book value per share
5.47K
-
4.56K
16.76%
4.50K
1.27%
4.38K
2.63%
4.27K
2.62%
4.69K
9.96%
4.51K
3.75%
4.60K
1.84%
4.66K
1.29%
10.04K
115.49%
working capital
30.03B
-
20.38B
32.14%
14.29B
29.87%
12.77B
10.67%
-251.81M
101.97%
-26.14B
10,279.19%
11.04B
142.26%
-26.16B
336.87%
-44.96B
71.88%
-57.81B
28.57%

All numbers in (except ratios and percentages)